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Table S1. Edge weights in an 8 by 8 constructed symmetric matrix by ND and 
BND models (Fig.1c in the text). 
Node 
ID 
Node 
ID 
Original Edge 
weight 
Edge weight rebuilt 
by ND noise model 
Edge weight rebuilt 
by BND noise model 
1 2 0 2.95E+13 3.69E+12 
1 3 0 2.23E+13 1.95E+13 
1 4 0 1.67E+14 2.08E+13 
1 5 0.369257 7.93E+14 6.94E+14 
1 6 0.597762 3.46E+14 3.03E+14 
1 7 0 6.87E+14 8.59E+13 
1 8 0 2.56E+13 2.24E+13 
2 3 0.757482 1.32E+12 1.15E+12 
2 4 0 9.83E+12 1.23E+12 
2 5 0 4.68E+13 4.09E+13 
2 6 0 2.04E+13 1.79E+13 
2 7 0 4.05E+13 5.06E+12 
2 8 0.490291 1.51E+12 1.32E+12 
3 4 0 7.45E+12 6.52E+12 
3 5 0 3.54E+13 4.43E+12 
3 6 0 1.55E+13 1.93E+12 
3 7 0 3.07E+13 2.69E+13 
3 8 0 1.15E+12 1.43E+11 
4 5 0.086159 2.65E+14 2.31E+14 
4 6 0.284088 1.15E+14 1.01E+14 
4 7 0 2.29E+14 2.86E+13 
4 8 0 8.55E+12 7.48E+12 
5 6 0 5.49E+14 6.87E+13 
5 7 0.865322 1.09E+15 9.54E+14 
5 8 0 4.07E+13 5.08E+12 
6 7 0 4.76E+14 4.16E+14 
6 8 0 1.77E+13 2.22E+12 
7 8 0.016268 3.52E+13 3.08E+13 
 
 
  3
Table S2. Results for predicting protein residue contact maps on the CASP9 
dataset. 
Part 1 MI 
Evaluation 
methods Predictors |i-j|>23 24>|i-j|>11 12>|i-j|>5 |i-j|>5 
MI 10.39% 8.88% 9.45% 11.93%
MI+ND 21.60% 18.24% 18.15% 25.50%Top L/10 
MI+BND 26.29% 22.49% 21.15% 31.23%
MI 8.41% 7.48% 8.42% 10.32%
MI+ND 17.73% 14.44% 14.86% 21.95%Top L/5 
MI+BND 21.58% 17.53% 16.87% 26.99%
MI 6.12% 6.37% 7.62% 8.28%
MI+ND 12.95% 10.47% 11.37% 16.76%Top L/2 
MI+BND 15.49% 12.21% 12.61% 20.08%
MI 5.16% 5.41% 6.90% 6.96%
MI+ND 10.05% 8.18% 9.07% 13.18%Top L 
MI+BND 11.86% 9.32% 9.79% 15.66%
 
Part 2 MIp 
Evaluation 
methods Predictors |i-j|>23 24>|i-j|>11 12>|i-j|>5 |i-j|>5 
MIp 10.39% 8.79% 9.57% 11.74%
MIp+ND 22.22% 17.73% 18.23% 25.30%Top L/10 
MIp+BND 26.49% 21.93% 21.11% 30.46%
MIp 8.46% 7.37% 8.49% 10.26%
MIp+ND 18.13% 14.39% 15.32% 22.15%Top L/5 
MIp+BND 21.26% 17.43% 16.55% 26.57%
MIp 6.16% 6.41% 7.65% 8.31%
MIp+ND 13.19% 10.72% 11.60% 16.94%Top L/2 
MIp+BND 15.81% 12.52% 12.52% 19.86%
MIp 5.19% 5.38% 6.95% 7.01%
MIp+ND 10.25% 8.28% 9.21% 13.34%Top L 
MIp+BND 12.38% 9.71% 10.09% 15.72%
 
Part 3 DCA 
Evaluation 
methods Predictors |i-j|>23 24>|i-j|>11 12>|i-j|>5 |i-j|>5 
DCA 29.88% 24.76% 20.33% 31.89%
DCA+ND 29.86% 24.51% 22.72% 32.81%Top L/10 
DCA+BND 31.34% 25.68% 23.57% 35.00%
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DCA 24.93% 18.76% 16.93% 27.11%
DCA+ND 25.59% 19.52% 18.29% 28.82%Top L/5 
DCA+BND 26.34% 20.84% 19.53% 31.10%
DCA 17.69% 12.65% 12.70% 21.58%
DCA+ND 17.82% 13.07% 13.33% 22.76%Top L/2 
DCA+BND 18.87% 14.05% 14.28% 23.96%
DCA 12.71% 9.19% 9.97% 16.88%
DCA+ND 13.24% 9.64% 10.60% 17.40%Top L 
DCA+BND 14.00% 10.34% 11.02% 18.72%
 
Part 4 PSICOV 
Evaluation 
methods Predictors |i-j|>23 24>|i-j|>11 12>|i-j|>5 |i-j|>5 
PSICOV 31.94% 23.33% 22.14% 36.18%
PSICOV+ND 31.57% 22.26% 22.39% 36.22%Top L/10 
PSICOV+BND 33.70% 24.70% 24.92% 40.07%
PSICOV 25.02% 17.88% 17.70% 29.41%
PSICOV+ND 24.47% 17.16% 17.29% 30.46%Top L/5 
PSICOV+BND 26.21% 18.89% 18.97% 33.24%
PSICOV 17.53% 12.64% 13.09% 21.80%
PSICOV+ND 16.35% 11.91% 12.69% 21.83%Top L/2 
PSICOV+BND 17.38% 12.74% 13.51% 23.52%
PSICOV 13.18% 9.93% 10.60% 16.81%
PSICOV+ND 12.21% 9.13% 10.10% 16.34%Top L 
PSICOV+BND 12.94% 9.69% 10.51% 17.55%
 
Part 5 gDCA 
Evaluation 
methods Predictors |i-j|>23 24>|i-j|>11 12>|i-j|>5 |i-j|>5 
gDCA 34.29% 25.98% 21.50% 36.36%
gDCA+ND 35.32% 25.87% 20.89% 34.91%Top L/10 
gDCA+BND 35.87% 27.06% 22.27% 38.05%
gDCA 27.66% 20.75% 18.96% 31.18%
gDCA+ND 28.57% 20.39% 17.64% 30.30%Top L/5 
gDCA+BND 29.06% 20.87% 18.17% 32.56%
gDCA 20.71% 14.55% 14.32% 23.59%
gDCA+ND 20.02% 14.25% 13.63% 23.41%Top L/2 
gDCA+BND 20.10% 13.88% 14.37% 24.36%
gDCA 15.23% 10.98% 11.24% 18.83%
gDCA+ND 14.89% 10.49% 10.95% 18.53%Top L 
gDCA+BND 14.68% 10.35% 10.93% 18.75%
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Table S3. Results for predicting protein residue contact maps on the CASP10 
dataset. 
Part 1 MI 
Evaluation 
methods Predictors |i-j|>23 24>|i-j|>11 12>|i-j|>5 |i-j|>5 
MI 15.82% 17.42% 13.97% 19.36%
MI+ND 30.63% 33.12% 25.12% 38.60%Top L/10 
MI+BND 36.78% 37.06% 28.60% 42.75%
MI 13.82% 13.33% 11.85% 16.12%
MI+ND 25.45% 26.72% 19.68% 32.83%Top L/5 
MI+BND 30.77% 29.83% 22.05% 37.72%
MI 9.97% 9.96% 9.97% 13.01%
MI+ND 18.89% 18.83% 14.55% 25.71%Top L/2 
MI+BND 22.63% 21.17% 16.14% 29.38%
MI 7.71% 8.13% 8.20% 10.53%
MI+ND 14.15% 13.95% 11.14% 20.15%Top L 
MI+BND 16.69% 15.55% 12.07% 23.23%
 
Part 2 MIp 
Evaluation 
methods Predictors |i-j|>23 24>|i-j|>11 12>|i-j|>5 |i-j|>5 
MIp 15.82% 17.42% 14.06% 19.36%
MIp+ND 30.81% 33.23% 24.92% 38.70%Top L/10 
MIp+BND 36.53% 36.69% 28.29% 42.83%
MIp 13.82% 13.40% 11.90% 16.31%
MIp+ND 25.77% 26.88% 19.85% 33.22%Top L/5 
MIp+BND 30.99% 29.72% 22.11% 37.05%
MIp 10.02% 9.97% 10.27% 13.03%
MIp+ND 19.24% 18.98% 14.62% 25.76%Top L/2 
MIp+BND 22.88% 21.31% 16.17% 29.38%
MIp 7.69% 8.05% 8.36% 10.56%
MIp+ND 14.32% 14.14% 11.27% 20.33%Top L 
MIp+BND 16.98% 15.81% 12.31% 23.31%
 
Part 3 DCA 
Evaluation 
methods Predictors |i-j|>23 24>|i-j|>11 12>|i-j|>5 |i-j|>5 
DCA 40.74% 39.56% 29.50% 44.06%
DCA+ND 38.98% 39.10% 32.00% 46.07%Top L/10 
DCA+BND 41.42% 40.04% 33.80% 48.94%
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DCA 34.48% 32.30% 23.88% 39.66%
DCA+ND 34.24% 33.23% 25.88% 41.83%Top L/5 
DCA+BND 35.62% 33.83% 27.17% 43.78%
DCA 25.94% 22.81% 16.73% 33.00%
DCA+ND 25.96% 23.11% 17.16% 34.73%Top L/2 
DCA+BND 26.80% 24.02% 17.74% 36.14%
DCA 19.13% 16.55% 12.38% 26.71%
DCA+ND 18.79% 16.83% 12.24% 28.01%Top L 
DCA+BND 19.51% 17.39% 12.62% 29.11%
 
Part 4 PSICOV 
Evaluation 
methods Predictors |i-j|>23 24>|i-j|>11 12>|i-j|>5 |i-j|>5 
PSICOV 41.45% 41.61% 31.57% 51.58%
PSICOV+ND 39.89% 40.73% 30.80% 50.56%Top L/10 
PSICOV+BND 41.55% 40.66% 33.48% 51.48%
PSICOV 35.87% 32.63% 24.69% 44.82%
PSICOV+ND 34.75% 31.33% 23.84% 44.48%Top L/5 
PSICOV+BND 36.50% 32.28% 24.96% 46.47%
PSICOV 26.72% 22.55% 17.04% 35.57%
PSICOV+ND 24.81% 20.91% 16.10% 34.97%Top L/2 
PSICOV+BND 25.99% 21.87% 16.50% 36.18%
PSICOV 18.90% 16.63% 12.86% 27.67%
PSICOV+ND 17.14% 15.06% 11.75% 26.49%Top L 
PSICOV+BND 17.94% 15.99% 12.04% 27.47%
 
Part 5 gDCA 
Evaluation 
methods Predictors |i-j|>23 24>|i-j|>11 12>|i-j|>5 |i-j|>5 
gDCA 45.22% 44.61% 34.05% 51.56%
gDCA+ND 42.78% 42.89% 33.51% 51.43%Top L/10 
gDCA+BND 45.13% 44.14% 35.42% 52.72%
gDCA 40.11% 36.95% 27.29% 47.07%
gDCA+ND 38.26% 34.30% 27.00% 47.32%Top L/5 
gDCA+BND 39.67% 36.23% 27.70% 48.54%
gDCA 30.36% 25.53% 18.60% 39.19%
gDCA+ND 27.57% 23.28% 17.22% 38.52%Top L/2 
gDCA+BND 29.35% 24.42% 18.20% 40.06%
gDCA 22.25% 18.38% 13.53% 31.17%
gDCA+ND 19.16% 16.84% 12.51% 29.47%Top L 
gDCA+BND 20.65% 17.78% 12.99% 31.17%
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Table S4. Results for predicting protein residue contact maps on the hard targets 
in CASP9 dataset. 
Part 1 MI 
Evaluation 
methods Predictors |i-j|>23 24>|i-j|>11 12>|i-j|>5 |i-j|>5 
MI 7.62% 5.46% 7.32% 10.08% 
MI+ND  14.47%  13.07% 13.99% 18.37% Top L/10 
MI+BND  20.53%  18.13% 19.20%  27.02% 
MI 6.59% 4.45% 6.62% 8.17% 
MI+ND 13.04% 9.25% 12.37% 15.27% Top L/5 
MI+BND 16.41% 13.31% 14.54% 23.25% 
MI 4.81% 4.51% 6.14% 5.72% 
MI+ND 9.68% 7.31% 9.68% 12.02% Top L/2 
MI+BND 12.10% 9.35% 10.80% 16.80% 
MI 4.04% 4.51% 6.05% 5.05% 
MI+ND 7.45% 6.37% 7.84% 9.73% Top L 
MI+BND 9.01% 7.46% 8.48% 12.43% 
 
Part 2 MIp 
Evaluation 
methods Predictors |i-j|>23 24>|i-j|>11 12>|i-j|>5 |i-j|>5 
MIp 7.62% 5.46% 7.32% 10.25% 
MIp+ND 15.38% 12.26% 15.37% 18.63% Top L/10 
MIp+BND 20.88% 17.66% 20.01% 26.77% 
MIp 6.59% 4.45% 6.62% 8.17% 
MIp+ND 13.33% 9.29% 13.16% 15.22% Top L/5 
MIp+BND 15.75% 13.67% 14.83% 22.76% 
MIp 4.81% 4.56% 6.22% 5.72% 
MIp+ND 9.93% 7.54% 10.22% 12.27% Top L/2 
MIp+BND 12.14% 9.65% 10.85% 16.49% 
MIp 4.04% 4.43% 6.15% 5.10% 
MIp+ND 7.44% 6.39% 7.94% 10.00% Top L 
MIp+BND 9.23% 7.91% 8.74% 12.68% 
 
Part 3 DCA 
Evaluation 
methods Predictors |i-j|>23 24>|i-j|>11 12>|i-j|>5 |i-j|>5 
DCA 25.61% 17.61% 19.23% 28.14% 
DCA+ND 26.04% 16.79% 21.49% 27.49% Top L/10 
DCA+BND 24.56% 16.58% 21.32%  27.51% 
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DCA 19.96% 12.94% 14.54% 22.77% 
DCA+ND 19.75% 13.12% 15.92% 23.50% Top L/5 
DCA+BND 19.88% 14.48% 16.33% 25.37% 
DCA 12.43% 8.39% 10.47% 17.30% 
DCA+ND 12.60% 9.16% 10.55% 17.49% Top L/2 
DCA+BND 13.26% 10.24% 11.91% 18.60% 
DCA 8.62% 6.64% 8.22% 12.51% 
DCA+ND 9.37% 7.25% 8.78% 12.75% Top L 
DCA+BND 10.09% 8.02% 9.24% 13.88% 
 
Part 4 PSICOV 
Evaluation 
methods Predictors |i-j|>23 24>|i-j|>11 12>|i-j|>5 |i-j|>5 
PSICOV 23.43% 17.73% 18.14% 29.78% 
PSICOV+ND 22.63% 16.54% 17.68% 29.00% Top L/10 
PSICOV+BND 24.44% 17.33% 18.14% 30.63% 
PSICOV 17.35% 13.86% 14.14% 22.95% 
PSICOV+ND 16.61% 12.53% 13.15% 22.44% Top L/5 
PSICOV+BND 17.19% 12.85% 13.79% 24.25% 
PSICOV 12.72% 9.47% 10.95% 15.79% 
PSICOV+ND 11.74% 9.19% 9.92% 15.60% Top L/2 
PSICOV+BND 12.91% 10.13% 11.30% 16.18% 
PSICOV 9.59% 8.21% 8.81% 12.99% 
PSICOV+ND 9.20% 7.59% 8.45% 12.13% Top L 
PSICOV+BND 9.32% 8.06% 9.08% 13.20% 
 
Part 5 gDCA 
Evaluation 
methods Predictors |i-j|>23 24>|i-j|>11 12>|i-j|>5 |i-j|>5 
gDCA 29.30% 20.52% 18.57% 31.13%
gDCA+ND 29.55% 16.61% 17.68% 29.02%Top L/10 
gDCA+BND 29.53% 18.99% 18.91% 32.01%
gDCA 21.75% 15.75% 16.54% 26.98%
gDCA+ND 22.11% 13.74% 15.72% 24.63%Top L/5 
gDCA+BND 21.84% 14.79% 15.33% 25.81%
gDCA 15.16% 11.10% 11.68% 19.22%
gDCA+ND 13.97% 10.83% 11.41% 19.01%Top L/2 
gDCA+BND 13.57% 10.23% 12.09% 18.65%
gDCA 11.32% 8.14% 9.76% 15.24%
gDCA+ND 10.78% 7.64% 9.49% 14.56%Top L 
gDCA+BND 10.58% 7.82% 9.71% 14.11%
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Table S5. Results for predicting protein residue contact maps on the hard targets 
in CASP10 dataset. 
Part 1 MI 
Evaluation 
methods Predictors |i-j|>23 24>|i-j|>11 12>|i-j|>5 |i-j|>5 
MI 9.48% 12.60% 7.71% 10.88%
MI+ND 13.89% 21.72% 13.35% 19.99%Top L/10 
MI+BND 18.61% 23.47% 17.55% 24.09%
MI 8.27% 9.78% 7.05% 8.83%
MI+ND 12.04% 17.81% 10.48% 16.84%Top L/5 
MI+BND 15.72% 19.66% 13.21% 20.91%
MI 6.54% 6.98% 6.34% 7.33%
MI+ND 9.09% 12.63% 8.87% 13.12%Top L/2 
MI+BND 11.28% 14.61% 10.31% 15.25%
MI 5.35% 5.81% 5.69% 6.29%
MI+ND 7.07% 10.47% 7.84% 10.35%Top L 
MI+BND 8.82% 11.79% 8.74% 12.04%
 
Part 2 MIp 
Evaluation 
methods Predictors |i-j|>23 24>|i-j|>11 12>|i-j|>5 |i-j|>5 
MIp 9.48% 12.60% 7.71% 10.88% 
MIp+ND 13.99% 21.26% 13.66% 20.70% Top L/10 
MIp+BND 17.83% 22.62% 17.16% 24.09% 
MIp 8.27% 10.18% 7.05% 9.33% 
MIp+ND 12.04% 18.10% 11.08% 17.08% Top L/5 
MIp+BND 16.59% 19.89% 13.47% 20.51% 
MIp 6.70% 6.93% 7.28% 7.36% 
MIp+ND 9.61% 12.79% 9.03% 13.20% Top L/2 
MIp+BND 11.76% 14.87% 10.71% 15.41% 
MIp 5.30% 5.70% 6.22% 6.40% 
MIp+ND 7.32% 10.57% 7.71% 10.55% Top L 
MIp+BND 9.22% 12.00% 8.56% 12.44% 
 
Part 3 DCA 
Evaluation 
methods Predictors |i-j|>23 24>|i-j|>11 12>|i-j|>5 |i-j|>5 
DCA 19.08% 22.89% 17.09% 22.94%
DCA+ND 16.61% 21.07% 17.25% 24.28%Top L/10 
DCA+BND 20.30% 23.74% 18.71% 28.53%
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DCA 14.34% 18.87% 12.93% 20.77%
DCA+ND 14.61% 19.12% 13.96% 21.51%Top L/5 
DCA+BND 15.67% 19.61% 15.45% 23.85%
DCA 11.44% 14.74% 9.51% 16.57%
DCA+ND 11.13% 15.58% 10.45% 17.51%Top L/2 
DCA+BND 11.74% 16.19% 10.87% 18.72%
DCA 9.16% 11.88% 7.94% 13.06%
DCA+ND 8.46% 12.58% 8.43% 14.03%Top L 
DCA+BND 8.75% 13.28% 8.97% 14.78%
 
Part 4 PSICOV 
Evaluation 
methods Predictors |i-j|>23 24>|i-j|>11 12>|i-j|>5 |i-j|>5 
PSICOV 17.58% 24.89% 15.62% 27.20%
PSICOV+ND 16.10% 24.12% 13.96% 27.49%Top L/10 
PSICOV+BND 19.09% 23.33% 15.82% 29.83%
PSICOV 15.39% 18.77% 11.14% 21.90%
PSICOV+ND 14.11% 18.68% 11.45% 22.24%Top L/5 
PSICOV+BND 16.10% 18.81% 11.60% 24.37%
PSICOV 11.34% 14.65% 9.74% 16.89%
PSICOV+ND 10.66% 14.28% 9.49% 16.95%Top L/2 
PSICOV+BND 11.11% 15.38% 9.54% 17.38%
PSICOV 8.62% 12.01% 9.66% 13.13%
PSICOV+ND 7.93% 11.67% 9.10% 13.05%Top L 
PSICOV+BND 8.15% 11.94% 9.27% 13.94%
 
Part 5 gDCA 
Evaluation 
methods Predictors |i-j|>23 24>|i-j|>11 12>|i-j|>5 |i-j|>5 
gDCA 20.86% 27.05% 17.10% 27.90%
gDCA+ND 19.28% 22.49% 16.23% 27.39%Top L/10 
gDCA+BND 21.82% 25.23% 16.80% 28.65%
gDCA 18.04% 21.73% 14.69% 23.79%
gDCA+ND 16.56% 19.99% 14.00% 24.35%Top L/5 
gDCA+BND 17.66% 21.35% 12.98% 25.67%
gDCA 13.31% 16.74% 10.73% 19.11%
gDCA+ND 11.42% 15.62% 10.69% 19.24%Top L/2 
gDCA+BND 12.48% 16.42% 10.73% 20.22%
gDCA 10.24% 13.22% 9.46% 15.10%
gDCA+ND 8.68% 12.96% 9.03% 15.38%Top L 
gDCA+BND 9.36% 13.70% 9.02% 15.95%
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Table S6. Results for predicting protein residue contact maps on the PSICOV 
dataset. 
Part 1 MI 
Evaluation 
methods Predictors |i-j|>23 24>|i-j|>11 12>|i-j|>5 |i-j|>5 
MI 29.12% 22.26% 19.83% 30.28%
MI+ND 55.04% 45.59% 39.74% 61.93%Top L/10 
MI+BND 60.76% 50.03% 43.11% 66.36%
MI 23.15% 16.95% 16.17% 25.08%
MI+ND 46.89% 35.47% 30.37% 53.90%Top L/5 
MI+BND 52.23% 39.96% 33.28% 58.84%
MI 16.33% 12.39% 11.94% 18.71%
MI+ND 33.58% 22.41% 19.70% 42.11%Top L/2 
MI+BND 38.61% 25.77% 21.34% 46.19%
MI 12.42% 9.32% 9.84% 15.50%
MI+ND 24.18% 15.15% 13.81% 31.83%Top L 
MI+BND 27.99% 17.19% 14.81% 35.57%
 
Part 2 MIp 
Evaluation 
methods Predictors |i-j|>23 24>|i-j|>11 12>|i-j|>5 |i-j|>5 
MIp 29.12% 22.26% 19.83% 30.28%
MIp+ND 55.15% 45.68% 39.66% 62.07%Top L/10 
MIp+BND 60.20% 50.12% 43.29% 65.83%
MIp 23.15% 16.95% 16.17% 25.08%
MIp+ND 46.96% 35.53% 30.60% 53.96%Top L/5 
MIp+BND 52.29% 40.03% 33.26% 58.87%
MIp 16.33% 12.39% 11.94% 18.71%
MIp+ND 33.86% 22.60% 19.94% 42.21%Top L/2 
MIp+BND 38.73% 25.96% 21.57% 46.11%
MIp 12.42% 9.32% 9.84% 15.50%
MIp+ND 24.35% 15.36% 13.88% 31.90%Top L 
MIp+BND 28.11% 17.25% 14.92% 35.59%
 
Part 3 DCA 
Evaluation 
methods Predictors |i-j|>23 24>|i-j|>11 12>|i-j|>5 |i-j|>5 
DCA 54.92% 53.45% 43.33% 60.14%
DCA+ND 56.06% 54.89% 46.37% 63.57%Top L/10 
DCA+BND 58.03% 56.86% 48.73% 65.96%
  12
DCA 50.55% 42.81% 35.22% 56.45%
DCA+ND 51.42% 44.30% 36.86% 58.66%Top L/5 
DCA+BND 53.44% 45.49% 37.61% 60.92%
DCA 40.00% 26.58% 22.51% 47.98%
DCA+ND 40.81% 27.04% 22.61% 49.92%Top L/2 
DCA+BND 42.39% 28.24% 23.34% 51.66%
DCA 29.18% 17.02% 15.18% 38.35%
DCA+ND 29.58% 17.00% 14.60% 39.81%Top L 
DCA+BND 30.72% 17.69% 15.14% 41.11%
 
Part 4 PSICOV 
Evaluation 
methods Predictors |i-j|>23 24>|i-j|>11 12>|i-j|>5 |i-j|>5 
PSICOV 71.77% 58.11% 50.95% 77.11%
PSICOV+ND 70.53% 56.97% 49.72% 76.66%Top L/10 
PSICOV+BND 71.22% 57.60% 51.25% 77.03%
PSICOV 62.56% 45.87% 38.62% 71.19%
PSICOV+ND 60.69% 43.27% 36.77% 70.28%Top L/5 
PSICOV+BND 62.42% 44.82% 38.06% 70.65%
PSICOV 44.74% 27.81% 23.94% 56.22%
PSICOV+ND 42.10% 25.09% 21.68% 54.63%Top L/2 
PSICOV+BND 44.05% 26.29% 22.71% 56.39%
PSICOV 31.48% 17.96% 16.12% 42.55%
PSICOV+ND 28.60% 15.87% 14.16% 39.87%Top L 
PSICOV+BND 29.91% 16.35% 14.82% 41.42%
 
Part 5 gDCA 
Evaluation 
methods Predictors |i-j|>23 24>|i-j|>11 12>|i-j|>5 |i-j|>5 
gDCA 72.86% 60.79% 54.59% 76.56%
gDCA+ND 72.86% 61.51% 54.04% 78.73%Top L/10 
gDCA+BND 73.62% 62.96% 56.63% 78.52%
gDCA 64.70% 50.28% 42.15% 71.81%
gDCA+ND 64.31% 47.48% 40.33% 72.11%Top L/5 
gDCA+BND 66.38% 50.16% 42.44% 73.86%
gDCA 50.61% 31.81% 26.32% 59.94%
gDCA+ND 47.27% 28.24% 23.85% 59.04%Top L/2 
gDCA+BND 50.39% 30.19% 25.41% 61.59%
gDCA 36.90% 20.51% 17.37% 47.72%
gDCA+ND 32.24% 17.71% 15.56% 44.25%Top L 
gDCA+BND 35.19% 19.02% 16.55% 47.42%
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Table S7. Results for predicting protein residue contact maps on the CASP9 
dataset at different cutoff values of long-range contacts. 
Part 1 MI 
Evaluation 
methods Predictors   |i-j|>23      |i-j|>20      |i-j|>15  |i-j|>8 
MI 10.39% 10.68% 10.68% 11.59%
MI+ND 21.60% 22.26% 23.28% 25.19%Top L/10 
MI+BND 26.29% 27.66% 28.81% 31.44%
MI 8.41% 8.58% 9.09% 10.03%
MI+ND 17.73% 18.68% 19.65% 21.50%Top L/5 
MI+BND 21.58% 22.40% 23.49% 26.34%
MI 6.12% 6.51% 6.98% 7.58%
MI+ND 12.95% 13.43% 14.22% 16.16%Top L/2 
MI+BND 15.49% 16.38% 17.36% 19.37%
MI 5.16% 5.43% 5.82% 6.47%
MI+ND 10.05% 10.52% 11.31% 12.47%Top L 
MI+BND 11.86% 12.55% 13.39% 14.90%
 
Part 2 MIp 
Evaluation 
methods Predictors   |i-j|>23      |i-j|>20      |i-j|>15  |i-j|>8 
MIp 10.39% 10.68% 10.68% 11.37%
MIp+ND 22.22% 22.64% 23.56% 25.28%Top L/10 
MIp+BND 26.49% 27.24% 28.80% 30.40%
MIp 8.46% 8.66% 9.06% 9.94%
MIp+ND 18.13% 18.79% 19.82% 21.64%Top L/5 
MIp+BND 21.26% 22.74% 23.36% 25.75%
MIp 6.16% 6.54% 6.95% 7.60%
MIp+ND 13.19% 13.80% 14.59% 16.23%Top L/2 
MIp+BND 15.81% 16.50% 17.50% 19.45%
MIp 5.19% 5.44% 5.82% 6.44%
MIp+ND 10.25% 10.76% 11.43% 12.58%Top L 
MIp+BND 12.38% 12.96% 13.79% 14.99%
 
Part 3 DCA 
Evaluation 
methods Predictors   |i-j|>23      |i-j|>20      |i-j|>15  |i-j|>8 
DCA 29.88% 30.49% 31.21% 33.19%
DCA+ND 29.86% 30.51% 31.80% 33.90%Top L/10 
DCA+BND 31.34% 31.42% 32.89% 35.67%
  14
DCA 24.93% 25.81% 26.75% 27.82%
DCA+ND 25.59% 26.46% 27.56% 28.58%Top L/5 
DCA+BND 26.34% 27.32% 28.64% 30.86%
DCA 17.69% 18.61% 19.73% 21.63%
DCA+ND 17.82% 18.78% 20.13% 22.14%Top L/2 
DCA+BND 18.87% 19.75% 21.30% 23.24%
DCA 12.71% 13.50% 14.59% 16.25%
DCA+ND 13.24% 13.87% 14.93% 16.64%Top L 
DCA+BND 14.00% 14.83% 15.94% 17.61%
 
Part 4 PSICOV 
Evaluation 
methods Predictors   |i-j|>23      |i-j|>20      |i-j|>15  |i-j|>8
PSICOV 31.94% 32.21% 33.90% 36.73%
PSICOV+ND 31.57% 31.99% 33.32% 36.70%Top L/10 
PSICOV+BND 33.70% 34.23% 35.89% 39.54%
PSICOV 25.02% 26.28% 27.16% 29.76%
PSICOV+ND 24.47% 25.52% 26.88% 29.93%Top L/5 
PSICOV+BND 26.21% 27.58% 28.94% 32.62%
PSICOV 17.53% 18.56% 19.27% 20.97%
PSICOV+ND 16.35% 17.39% 18.50% 20.55%Top L/2 
PSICOV+BND 17.38% 18.19% 19.47% 22.22%
PSICOV 13.18% 13.83% 14.70% 16.16%
PSICOV+ND 12.21% 12.62% 13.55% 15.27%Top L 
PSICOV+BND 12.94% 13.50% 14.38% 16.39%
 
Part 5 gDCA 
Evaluation 
methods Predictors |i-j|>23 24>|i-j|>11 12>|i-j|>5 |i-j|>5 
gDCA 34.29% 35.67% 36.55% 38.02%
gDCA+ND 35.32% 35.67% 36.32% 37.44%Top L/10 
gDCA+BND 35.87% 36.57% 37.37% 39.63%
gDCA 27.66% 28.95% 29.73% 32.23%
gDCA+ND 28.57% 29.68% 30.84% 32.18%Top L/5 
gDCA+BND 29.06% 30.17% 31.25% 33.90%
gDCA 20.71% 21.43% 21.99% 23.65%
gDCA+ND 20.02% 21.15% 22.44% 23.99%Top L/2 
gDCA+BND 20.10% 20.99% 22.36% 24.39%
gDCA 15.23% 16.09% 17.09% 18.36%
gDCA+ND 14.89% 15.64% 16.66% 18.13%Top L 
gDCA+BND 14.68% 15.56% 16.66% 18.22%
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Table S8. Results for predicting protein residue contact maps on the CASP10 
dataset at different cutoff values of long-range contacts. 
Part 1 MI 
Evaluation 
methods Predictors   |i-j|>23      |i-j|>20      |i-j|>15  |i-j|>8 
MI 15.82% 18.81% 17.77% 19.77%
MI+ND 30.63% 35.39% 36.62% 40.60%Top L/10 
MI+BND 36.78% 39.65% 40.66% 44.97%
MI 13.82% 16.30% 14.70% 16.78%
MI+ND 25.45% 29.22% 30.98% 33.80%Top L/5 
MI+BND 30.77% 34.33% 36.02% 39.24%
MI 9.97% 11.97% 11.68% 12.69%
MI+ND 18.89% 21.93% 23.71% 26.14%Top L/2 
MI+BND 22.63% 26.04% 27.79% 30.48%
MI 7.71% 9.67% 9.47% 9.84%
MI+ND 14.15% 17.05% 18.31% 20.03%Top L 
MI+BND 16.69% 19.61% 21.25% 23.36%
 
Part 2 MIp 
Evaluation 
methods Predictors   |i-j|>23      |i-j|>20      |i-j|>15  |i-j|>8 
MIp 15.82% 18.81% 17.77% 19.86%
MIp+ND 30.81% 35.52% 37.01% 40.45%Top L/10 
MIp+BND 36.53% 39.63% 40.81% 45.05%
MIp 13.82% 16.30% 14.82% 16.99%
MIp+ND 25.77% 29.73% 31.32% 34.45%Top L/5 
MIp+BND 30.99% 34.81% 36.00% 39.16%
MIp 10.02% 11.97% 11.68% 12.69%
MIp+ND 19.24% 22.44% 23.88% 26.26%Top L/2 
MIp+BND 22.88% 26.49% 28.44% 30.67%
MIp 7.69% 9.66% 9.43% 9.99%
MIp+ND 14.32% 17.26% 18.68% 20.33%Top L 
MIp+BND 16.98% 19.84% 21.43% 23.72%
 
Part 3 DCA 
Evaluation 
methods Predictors   |i-j|>23      |i-j|>20      |i-j|>15  |i-j|>8 
DCA 40.74% 44.21% 44.66% 46.96%
DCA+ND 38.98% 42.98% 44.49% 47.13%Top L/10 
DCA+BND 41.42% 45.41% 46.73% 49.49%
  16
DCA 34.48% 38.47% 39.87% 41.94%
DCA+ND 34.24% 38.98% 39.92% 42.08%Top L/5 
DCA+BND 35.62% 40.18% 41.51% 44.11%
DCA 25.94% 29.80% 31.88% 33.78%
DCA+ND 25.96% 30.04% 31.81% 34.36%Top L/2 
DCA+BND 26.80% 31.17% 33.19% 35.52%
DCA 19.13% 22.87% 24.84% 26.69%
DCA+ND 18.79% 22.55% 24.59% 27.27%Top L 
DCA+BND 19.51% 23.30% 25.55% 28.24%
 
Part 4 PSICOV 
Evaluation 
methods Predictors   |i-j|>23      |i-j|>20      |i-j|>15  |i-j|>8
PSICOV 41.45% 45.29% 47.93% 52.01%
PSICOV+ND 39.89% 44.20% 46.70% 50.13%Top L/10 
PSICOV+BND 41.55% 45.46% 47.19% 50.99%
PSICOV 35.87% 40.31% 41.40% 45.37%
PSICOV+ND 34.75% 39.23% 40.52% 44.21%Top L/5 
PSICOV+BND 36.50% 40.68% 42.74% 45.89%
PSICOV 26.72% 30.69% 33.03% 35.09%
PSICOV+ND 24.81% 29.12% 31.58% 34.08%Top L/2 
PSICOV+BND 25.99% 30.52% 32.59% 35.27%
PSICOV 18.90% 22.26% 24.33% 26.72%
PSICOV+ND 17.14% 20.62% 22.58% 25.25%Top L 
PSICOV+BND 17.94% 15.99% 12.04% 27.47%
 
Part 5 gDCA 
Evaluation 
methods Predictors |i-j|>23 24>|i-j|>11 12>|i-j|>5 |i-j|>5 
gDCA 45.22% 47.87% 49.55% 51.77%
gDCA+ND 42.78% 46.16% 47.82% 50.89%Top L/10 
gDCA+BND 45.13% 47.99% 48.89% 51.87%
gDCA 40.11% 44.07% 45.97% 47.68%
gDCA+ND 38.26% 42.79% 44.02% 46.96%Top L/5 
gDCA+BND 39.67% 44.08% 46.07% 48.32%
gDCA 30.36% 34.74% 37.07% 39.32%
gDCA+ND 27.57% 32.17% 34.35% 37.38%Top L/2 
gDCA+BND 29.35% 33.74% 36.44% 39.22%
gDCA 22.25% 26.33% 28.43% 30.74%
gDCA+ND 19.16% 23.26% 25.37% 28.21%Top L 
gDCA+BND 20.65% 24.67% 27.02% 30.15%
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Table S9. Results for predicting protein residue contact maps on the PSICOV 
dataset at different cutoff values of long-range contacts. 
Part 1 MI 
Evaluation 
methods Predictors   |i-j|>23      |i-j|>20      |i-j|>15  |i-j|>8 
MI 29.12% 29.91% 32.40% 31.83%
MI+ND 55.04% 55.65% 58.04% 61.57%Top L/10 
MI+BND 60.76% 61.32% 64.08% 67.30%
MI 23.15% 23.54% 24.73% 25.79%
MI+ND 46.89% 47.76% 50.19% 53.64%Top L/5 
MI+BND 52.23% 53.87% 56.63% 59.45%
MI 16.33% 17.25% 18.40% 18.91%
MI+ND 33.58% 35.30% 37.59% 41.55%Top L/2 
MI+BND 38.61% 40.46% 43.21% 46.32%
MI 12.42% 13.10% 14.03% 15.14%
MI+ND 24.18% 25.73% 27.72% 30.57%Top L 
MI+BND 27.99% 29.72% 31.95% 35.09%
 
Part 2 MIp 
Evaluation 
methods Predictors   |i-j|>23      |i-j|>20      |i-j|>15  |i-j|>8 
MIp 29.12% 29.91% 32.40% 31.83%
MIp+ND 55.15% 55.89% 58.28% 61.69%Top L/10 
MIp+BND 60.20% 61.02% 63.79% 66.99%
MIp 23.15% 23.54% 24.73% 25.79%
MIp+ND 46.96% 47.96% 50.23% 53.59%Top L/5 
MIp+BND 52.29% 53.94% 56.73% 59.35%
MIp 16.33% 17.25% 18.40% 18.91%
MIp+ND 33.86% 35.45% 37.81% 41.74%Top L/2 
MIp+BND 38.73% 40.56% 43.20% 46.42%
MIp 12.42% 13.10% 14.03% 15.14%
MIp+ND 24.35% 25.82% 27.89% 30.66%Top L 
MIp+BND 28.11% 29.75% 32.16% 35.26%
 
Part 3 DCA 
Evaluation 
methods Predictors   |i-j|>23      |i-j|>20      |i-j|>15  |i-j|>8 
DCA 54.92% 55.81% 57.94% 60.26%
DCA+ND 56.06% 57.27% 60.27% 63.70%Top L/10 
DCA+BND 58.03% 58.85% 62.01% 65.54%
  18
DCA 50.55% 51.54% 53.84% 57.02%
DCA+ND 51.42% 52.83% 55.09% 58.14%Top L/5 
DCA+BND 53.44% 54.51% 56.92% 60.46%
DCA 40.00% 41.68% 44.33% 47.53%
DCA+ND 40.81% 42.77% 45.55% 49.02%Top L/2 
DCA+BND 42.39% 44.34% 47.18% 50.51%
DCA 29.18% 30.81% 33.56% 37.24%
DCA+ND 29.58% 31.36% 34.18% 37.93%Top L 
DCA+BND 30.72% 32.74% 35.52% 39.48%
 
Part 4 PSICOV 
Evaluation 
methods Predictors   |i-j|>23      |i-j|>20      |i-j|>15  |i-j|>8
PSICOV 71.77% 72.84% 74.96% 76.88%
PSICOV+ND 70.53% 71.95% 74.27% 77.08%Top L/10 
PSICOV+BND 71.22% 72.37% 74.51% 77.01%
PSICOV 62.56% 64.21% 67.01% 70.59%
PSICOV+ND 60.69% 62.57% 65.85% 69.56%Top L/5 
PSICOV+BND 62.42% 63.77% 66.81% 70.29%
PSICOV 44.74% 46.99% 50.02% 54.79%
PSICOV+ND 42.10% 44.58% 47.92% 52.85%Top L/2 
PSICOV+BND 44.05% 46.26% 49.83% 54.82%
PSICOV 31.48% 33.43% 36.22% 40.49%
PSICOV+ND 28.60% 30.50% 33.18% 37.65%Top L 
PSICOV+BND 29.91% 31.90% 34.64% 39.14%
 
Part 5 gDCA 
Evaluation 
methods Predictors |i-j|>23 24>|i-j|>11 12>|i-j|>5 |i-j|>5 
gDCA 72.86% 73.91% 76.00% 76.67%
gDCA+ND 72.86% 73.99% 76.14% 78.80%Top L/10 
gDCA+BND 73.62% 74.63% 77.08% 78.80%
gDCA 64.70% 66.27% 68.50% 71.63%
gDCA+ND 64.31% 65.55% 68.18% 72.12%Top L/5 
gDCA+BND 66.38% 67.62% 69.64% 73.64%
gDCA 50.61% 52.72% 55.81% 59.38%
gDCA+ND 47.27% 49.43% 52.82% 58.31%Top L/2 
gDCA+BND 50.39% 52.43% 55.96% 61.13%
gDCA 36.90% 38.94% 41.80% 47.19%
gDCA+ND 32.24% 34.27% 37.25% 43.49%Top L 
gDCA+BND 35.19% 37.31% 40.61% 46.77%
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Table S10. The p-value in the t-test on all contacts. 
Method CASP9 |i-j|>5 
CASP9 
|i-j|>23 
CASP10
|i-j|>5 
CASP10
|i-j|>23 
PSICOV 
|i-j|>5 
PSICOV
|i-j|>23 
MI/ND 1.24E-05 5.05E-03 9.06E-04 1.69E-03 7.40E-14 1.99E-06
MI/BND 3.57E-03 4.12E-03 1.38E-03 2.42E-03 8.55E-14 2.20E-06
ND/BND 1.75E-03 1.18E-02 3.48E-03 1.28E-02 1.89E-05 1.08E-05
MIp/ND 5.44E-06 3.01E-03 9.15E-04 7.28E-05 7.34E-14 1.99E-06
MIp/BND 3.69E-04 5.01E-03 1.40E-03 7.17E-04 8.35E-14 2.17E-06
ND/BND 3.18E-04 6.95E-03 1.36E-02 9.81E-03 1.19E-03 3.96E-05
DCA/ND 1.00E-07 4.54E-05 3.55E-05 3.54E-06 7.55E-14 2.08E-06
DCA/BND 1.99E-07 7.45E-05 2.91E-04 3.93E-07 4.79E-13 8.29E-06
ND/BND 9.73E-04 3.12E-03 2.83E-04 3.32E-04 5.66E-13 1.08E-05
PSICOV/ND 2.32E-09 3.27E-06 8.11E-06 8.11E-06 5.78E-13 5.30E-06
PSICOV/BND 2.16E-07 1.00E-05 4.25E-06 4.25E-06 2.63E-13 3.83E-06
ND/BND 6.72E-08 2.12E-04 8.80E-05 8.80E-05 1.70E-11 5.95E-05
gDCA/ND 4.13E-04 3.01E-03 7.19E-03 8.75E-03 1.23E-02 1.06E-02
gDCA/BND 2.78E-03 9.87E-03 1.43E-02 2.50E-02 6.48E-02 4.80E-02
ND/BND 3.30E-02 2.20E-02 5.55E-03 1.48E-02 4.78E-03 6.41E-03
 
